Trial intelligence / Profile preview

MAGELLAN-2 trial of glecaprevir + pibrentasvir in post-liver or post-renal transplant adults with chronic hepatitis C

2015-005616-14Phase 3Completed

Sponsor

AbbVie Inc.

Start

Feb 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1